| abstract |
The present invention discloses the use of A-nor-5alpha-androstane compounds for preparing anti-malignant tumor medicine. In vitro experiments show that the A-nor-5alpha-Androstane Compounds have activity for inhibiting a variety of tumor cells in vitroļ¼and growth inhibition rate averages more than 85%.In vivo experiments show that the A-nor-5alpha-androstane compounds can inhibit a variety of tumors, such as colon cancer, hepatic cancer, lung cancer, breast cancer, B16 melanoma etc. The invention also discloses the composition of anticancer drug and the method for treating cancer. |